Klinische Psychokardiologie

1. Doering S, Herpertz S, Hofmann T, Rose M, Imbierowicz K, Geiser F, Croy C, Weidner K, Rademacher J, Michalek S, Morawa E, Erim Y, Teigelack P, Teufel M, Hartmann A, Lahmann C, Peters EMJ, Kruse J, von Boetticher D, Herrmann-Lingen C, Nöhre M, de Zwaan M, Dinger U, Friederich HC, Niecke A, Albus C, Zwerenz R, Beutel M, Roenneberg C, Henningsen P, Stein B, Waller C, Hake K, Spitzer C, Stengel A, Zipfel S, Weimer K, Guendel H, Kessler H. What Kind of Patients Receive Inpatient and Day-hospital Treatment in Departments of Psychosomatic Medicine and Psychotherapy in Germany? Psychother Psychosom 2022; https://doi.org/10.1159/000527881
2. Eisele M, Rakebrandt A, Boczor S, Blozik E, Träder JM, Störk S, Herrmann-Lingen C, Scherer M. The association of general practitioners' awareness of depression and anxiety with change in quality of life in heart failure patients: results of the prospective observational RECODE-HF cohort study. Fam Pract. 2022;39:346-353; https://doi.org/10.1093/fampra/cmab138
3. Hashemi D, Mende M, Trippel TD, Petutschnigg J, Hasenfuß G, Nolte K, Herrmann-Lingen C, Feuerstein A, Langhammer R, Tschöpe C, Pieske B, Wachter R, Edelmann F. Evaluation of the prognostic value of the HFA-PEFF Score in a population at risk: results from the prospective DIAST-CHF cohort. ESC Heart Fail epub 2022; https://doi.org/10.1002/ehf2.14131
4. Herrmann-Lingen C, Treating depression in patients with heart failure – what is (not) recommended? Eur J Prevent Cardiol. 2022;29:2137-2139; https://doi.org/10.1093/eurjpc/zwac092
5. Kappe H, Meyer T, Timmermann J, Herrmann-Lingen C. Evaluation eines fakultativ multimodalen Behandlungskonzeptes in einem medizinischen Versorgungszentrum mit psychosomatischem Schwerpunkt. Ärztl Psychother 2022;17:51-58.
6. Ladwig KH, Baghai-Vadji T, Doyle F, Hamer M, Herrmann-Lingen C, Kunschitz E, Lemogne C, Beresnevaite M, Compare A, von Känel R, Sager H, Kop WJ. Mental Health-Related Risk Factors and Interventions in the Clinical Care of Patients with Heart Failure. A Position Paper endorsed by the European Association of Preventive Cardiology (EAPC). Eur J Prevent Cardiol 2022;29:1124-1141. DOI: 10.1093/eurjpc/zwac006.
7. Lodder P, Wicherts JM, Antens M, Albus C, Bessonov IS, Condén E, Gostoli S, Grande G, Hedberg P, Herrmann-Lingen C, Jaarsma T, Koo M, Lin TK, Meyer T, Pushkarev G, Rafanelli C, Raykh OI, Schaan de Quadros A, Schmidt M, Sumin AN, Utens L, van Domburg RT, van Veldhuisen FJ, Kupper N. Type D personality as a risk factor for adverse outcome in patients with cardiovascular disease: an individual patient data meta-analysis. Psychosom Med (in press)
8. Reinhardt C, Harden M, Herrmann‑Lingen C, Rittmeyer A, Andreas S. Smoking cessation by combined medication and counselling: a feasibility study in lung cancer patients. BMC Pulmonary Medicine 2022;22:252. https://doi.org/10.1186/s12890-022-02048-1
9. Sadlonova M, Löser JK, Celano CM, Kleiber C, Broschmann D, Herrmann-Lingen C. Changes in Treatment Outcomes in Patients Undergoing an Integrated Psychosomatic Inpatient Treatment: Results From a Cohort Study. Front Psychiatry 2022 https://doi.org/10.3389/fpsyt.2022.964879
10. Sadlonova M, Nagel J, Becker S, Neumann S, Staab J, Meyer T, Celano CM, Amonoo HL, Fangauf SV, Herrmann-Lingen C, Kutschka I, Friedrich M. Feasibility and Preliminary Efficacy of Peri-operative Interventions in Patients Undergoing Coronary Artery Bypass Grafting: The Randomized Controlled I-COPE Trial. Eur J cardiothorac surg. 2022; 62:ezac041. https://doi.org/10.1093/ejcts/ezac041
11. Sadlonova M, Senges J, Nagel J, Celano C, Klasen-Max C Borggrefe M, Akin I, Thomas D, Schwarzbach CJ, Kleemann T, Schneider S, Hochadel M, Süselbeck T, Schwacke H, Alonso A, Haass M, Ladwig KH, Herrmann-Lingen C. Symptom Severity and Health-related Quality of Life in Patients with Atrial Fibrillation: Findings From The Observational ARENA Study. J Clin Med 2022, 11, 1140.  https://doi.org/10.3390/jcm11041140
12. Stamm B, Blaschke M, Wilken L, Wilde D, Heppner C, Leha A, Herrmann-Lingen C, Siggelkow H. The influence of conventional treatment on symptoms and complaints in patients with chronic postsurgical hypoparathyroidism. JBMR Plus2022;6:e10586.
13. Stolz M, Albus C, Beutel ME, Deter HC, Fritzsche K, Herrmann‑Lingen C, Michal M, Petrowski K, Ronel J, Schultz JH, Söllner W, Weber C, de Zwaan M, Krauth C. Assessment of health‑related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ‑5D‑3L and the SF‑6D. Eur J Health Econ 2022; epub 16.11.2022
14. Van den Houdt SCM, Albus C, Herrmann-Lingen C, Widdershoven J, Kupper N. Validity of a Multidimensional Comprehensive Psychosocial Screening Instrument Based on the ESC Cardiovascular Prevention Guidelines – Evidence from the General and Cardiovascular Patient Population. J Psychosom Res 2022;157:110791. https://doi.org/10.1016/j.jpsychores.2022.110791
15. Veiz E, Kieslich SK, Czesnik D, Herrmann-Lingen C, Meyer T, Staab J. Increased concentrations of circulating interleukins following non-invasive vagus nerve stimulation: Results from a randomized, sham-controlled, cross-over study in healthy subjects. Neuroimmunomodulation. 2022 May 16:1-10 (epub ahead of print).
16. Weber C, Fangauf SV, Michal M, Ronel J, Herrmann-Lingen C, Ladwig KH, Beutel M, Albus C, Soellner W, Perschel FH, de Zwaan M, Fritzsche K, Deter HC. Cortisol awakening reaction and anxiety in depressed coronary artery disease patients. J Clin Med 2022;11:374. https://doi.org/10.3390/jcm11020374 

Originalarbeiten

1. Boczor S, Eisele M, Rakebrandt A, Menzel A, Blozik E, Träder JM, Störk S, Herrmann-Lingen C, Scherer M, RECODE-HF study group (2021) Prognostic factors associated with quality of life in heart failure patients considering the use of the generic EQ-5D-5L™ in primary care: new follow-up results of the observational RECODE-HF study. BMC FAM PRACT 22(1): 202, doi: 10.1186/s12875-021-01554-1
2. Córdova MAC, Stausberg D, Wang B, Becker A, Rothenberger A, Herrmann-Lingen C, Meyer T, Staab J (2021) Headache Is Associated with Low Systolic Blood Pressure and Psychosocial Problems in German Adolescents: Results from the Population-Based German KiGGS Study. J CLIN MED 10(7): 1492, doi: 10.3390/jcm10071492
3. Eisele M, Harder M, Rakebrandt A, Boczor S, Marx G, Blozik E, Träder JM, Störk S, Herrmann-Lingen C, Scherer M (2021) Reply to: Dumping adherence: a person-centred response for primary care. FAM PRACT 38(2): 198-199, doi: 10.1093/fampra/cmaa106
4. Fitz J, Edelmann F, Hasenfuß G, Sandek A, Nolte K, Hashemi D, Trippel TD, Wachter R, Herrmann-Lingen C (2021) Influence of baseline parameters on one-year physical, mental, and health-related quality of life in patients with heart failure and preserved ejection fraction. ESC HEART FAIL Sep 4: ehf2.13593, doi: 10.1002/ehf2.13593
5. Kyaw Tha Tun E, Nagel J, Bosbach A, Bock S, Kielblock B, Siegmund-Schultze E, Herrmann-Lingen C (2021) Telephone-based peer support intervention to reduce depressive symptoms in women with coronary heart disease, a randomized controlled trial in Germany. WOMEN HEALTH 61(7): 619-632, doi: 10.1080/03630242.2021.1953208
6. Sadlonova M, Herrmann-Lingen C (2021) [Update Psychocardiology]. DEUT MED WOCHENSCHR 146(11): 738-741, doi: 10.1055/a-1218-9204
7. Sadlonova M, Gerecke B, Herrmann-Lingen C, Kutschka I (2021) Heart transplantation in the era of COVID-19 pandemic: delirium, post-transplant depression, and visitor restrictions; the role of liaison and inpatient psychosomatic treatment-a case report. Eur Heart J Case Rep 5(10): ytab355, doi: 10.1093/ehjcr/ytab355
8. Sadlonova M, Wasser K, Nagel J, Weber-Krüger M, Gröschel S, Uphaus T, Liman J, Hamann GF, Kermer P, Gröschel K, Herrmann-Lingen C, Wachter R (2021) Health-related quality of life, anxiety and depression up to 12 months post-stroke: Influence of sex, age, stroke severity and atrial fibrillation - A longitudinal subanalysis of the Find-AFRANDOMISED trial. J PSYCHOSOM RES 142: 110353, doi: 10.1016/j.jpsychores.2020.110353
9. Schnelle M, Leha A, Eidizadeh A, Fuhlrott K, Trippel TD, Hashemi D, Toischer K, Wachter R, Herrmann-Lingen C, Hasenfuß G, Pieske B, Binder L, Edelmann F (2021) Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial. CELLS-BASEL 10(10): 10102796, doi: 10.3390/cells10102796
10. Schwaab B, Bjarnason-Wehrens B, Meng K, Albus C, Salzwedel A, Schmid JP, Benzer W, Metz M, Jensen K, Rauch B, Bönner G, Brzoska P, Buhr-Schinner H, Charrier A, Cordes C, Dörr G, Eichler S, Exner AK, Fromm B, Gielen S, Glatz J, Gohlke H, Grilli M, Gysan D, Härtel U, Hahmann H, Herrmann-Lingen C, Karger G, Karoff M, Kiwus U, Knoglinger E, Krusch CW, Langheim E, Mann J, Max R, Metzendorf MI, Nebel R, Niebauer J, Predel HG, Preßler A, Razum O, Reiss N, Saure D, von Schacky C, Schütt M, Schultz K, Skoda EM, Steube D, Streibelt M, Stüttgen M, Stüttgen M, Teufel M, Tschanz H, Völler H, Vogel H, Westphal R (2021) Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 2. J CLIN MED 10(14): 3071, doi: 10.3390/jcm10143071
11. Trippel TD, Mende M, Düngen HD, Hashemi D, Petutschnigg J, Nolte K, Herrmann-Lingen C, Binder L, Hasenfuss G, Pieske B, Wachter R, Edelmann F (2021) The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study. ESC HEART FAIL 8(2): 829-841, doi: 10.1002/ehf2.13174
12. von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, Herrmann-Lingen C, Garfias Macedo T, Koziolek M, Noutsias M, Schulze PC, Wachter R, Hasenfuß G, Laufs U (2021) Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials. EUR J HEART FAIL 23(1): 92-113, doi: 10.1002/ejhf.1838

Originalarbeiten

1. Bosselmann L, Fangauf SV, Herbeck Belnap B, Chavanon ML, Nagel J, Neitzel C, Schertz A, Hummers E, Wachter R, Herrmann-Lingen C. Blended Collaborative Care in the Secondary Prevention of Coronary Heart Disease Improves Risk Factor Control: Results of a Randomized Feasibility Study. Eur J Cardiovasc Nurs 2020 Feb;19(2):134-141.
2. Petutschnigg J, Ferreira JP, Holzendorf V, Trippel TD, Hashemi D, Wachter R, Herrmann-Lingen C, Hasenfuß G, Zannad F, Pieske B, Edelmann F. Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post-hoc analysis of the ALDO-DHF trial. Eur J Heart Fail. 2020 Jan 7. doi: 10.1002/ejhf.1723.
3. Eisele M, Harder M, Rakebrandt A, Boczor S, Marx G, Blozik E, Träder JM, Störk S, Herrmann-Lingen C, Scherer M. Association of depression and anxiety with adherence in primary care patients with heart failure – Cross-sectional results of the observational RECODE-HF cohort study. Fam Pract. 2020 May 2;cmaa042. doi: 10.1093/fampra/cmaa042 (e-pub)
4. Meyer T, Rothe I, Staab J, Deter HC, Fangauf SV, Hamacher S, Hellmich M, Jünger J, Ladwig KH, Michal M, Petrowski K, Ronel J, Söllner W, Weber C, de Zwaan M, Williams RB, Albus C, Herrmann-Lingen C, SPIRR-CAD Investigators. Length Polymorphisms in the Angiotensin I-converting Enzyme Gene and the Serotonin-Transporter-linked Polymorphic Region constitute a Risk Haplotype for Depression in Patients with Coronary Artery Disease. Biochem Genet. 2020 May 5. doi: 10.1007/s10528-020-09967-w (e-pub)
5. Wilde D, Wilken L, Stamm B, Heppner C, Leha A, Blaschke M, Herrmann-Lingen C, Siggelkow H. Quantification of symptom load by a disease-specific questionnaire HPQ 28 and analysis of associated biochemical parameters in patients with postsurgical hypoparathyroidism JBMR Plus 2020, e10368
6. Bobenko A, Duvinage A, Mende M, Holzendorf V, Nolte K, Herrmann-Lingen C, Binder L, Düngen HD, Hasenfuss G, Pieske B, Wachter R, Edelmann F. Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction. Int J Cardiol Heart Vasc. 2020 May 7;28:100525.
7. Sadlonova M, Meyer T, Binder L, Wachter R, Edelmann F, Herrmann-Lingen C. Serum galectin-3 is inversely associated with anxiety in patients with cardiovascular risk factors. BioPsychoSoc Med 2020;14:24. doi: 10.1186/s13030-020-00195-7
8. Herrmann-Lingen C, Albus C, de Zwaan M, Geiser F, Heinemann K, Hellmich M, Michal M, Sadlonova M, Tostmann R; Wachter R, Herbeck Belnap B.Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial. BMC Cardiovasc Disord 2020;20:520 https://doi.org/10.1186/s12872-020-01810-9

Sonstige Zeitschriftenbeiträge

1. Herrmann-Lingen C, Wachter R. Psychological stress and incidence of atrial fibrillation. Eur J Prevent Cardiol. 2020 Jan 13:2047487319898022. 
2. von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, Herrmann-Lingen C, Garfias-Macedo T, Koziolek M, Noutsias M, Schulze PC, Wachter R, Hasenfuß G, Laufs U. Improving exercise capacity and quality of life using non-invasive heart failure treatments: Evidence from clinical trials. Eur J Heart Fail e-pub 2020, doi:10.1002/ejhf.1838.
3. Eisele M, Harder M, Rakebrandt A, Boczor Sigrid, Marx G, Blozik E, Traeder JM, Störk S, Herrmann-Lingen C, Scherer M. Reply to: Dumping adherence: a person-centred response for primary care. Fam Pract e-pub 2.10.2020
4. Herrmann-Lingen C. Mein Körper, meine Moleküle, meine Mikroben - Neues aus der psychosomatischen Grundlagenforschung. Psychodyn Psychother 2020;19:369–381. DOI 10.21706/pdp-19-4-369

Leitlinie

1. Albus C, Herrmann-Lingen C, Jensen K, Hackbusch M, Grilli M, Schwaab B, Rauch B. Psychologische Interventionen im Rahmen der KardReha. In: Deutsche Gesellschaft für Prävention und Rehabilitation von Herz- und Kreislauferkrankungen, Swiss Working Group for Cardiovascular Prevention, Rehabilitation and Sports Cardiology, Österreichische Kardiologische Gesellschaft. S3 – Leitlinie zur kardiologischen Rehabilitation (LL-KardReha) im deutschsprachigen Raum Europas, Deutschland, Österreich, Schweiz (D-A-CH), Langversion - Teil 1, 2019 AWMF Registernummer: 133/001,https://www.awmf.org/uploads/tx_szleitlinien/133-001l_S3-Kardiologische-Rehabilitation-in-D-A-CH_2020-12.pdf